Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients

Clinical trial NCT00042354 · COMPLETED

Trial details

NCT number: NCT00042354
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myelocytic, Acute, Pediatric

Start date: 2002-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.